MYELORX
MyeloRx is a biotechnology company that develops drugs for oncology and immune-related diseases based on the natural product triptolide. Importantly, triptolide and the plant from which it is extracted, Tripterygium Wilfordii Hook f, has been shown to be clinically active in acute leukemias as well as in immune-based diseases such as rheumatoid arthritis. MyeloRx has in-licensed a series of composition of matter patents covering proprietary analogs of the natural product.
MYELORX
Industry:
Biotechnology Health Care
Founded:
2007-01-01
Address:
Vallejo, California, United States
Country:
United States
Website Url:
http://www.myelorx.com
Status:
Active
Technology used in webpage:
GoDaddy CDN GoDaddy Website Builder
Official Site Inspections
http://www.myelorx.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.56 K
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "MyeloRx"
myelorx
MyeloRx, LLC is a privately held Northern California-based biotechnology company that develops drugs for oncology and immune-related diseases based on the natural product triptolide.See details»
MyeloRx - Crunchbase Company Profile & Funding
MyeloRx is a biotechnology company that develops drugs for oncology and immune-related diseases based on the natural product triptolide. Importantly, triptolide and the plant from …See details»
Development Portfolio - myelorx.com
MyeloRx is a development company advancing a portfolio of triptolide-based compounds through IND-enabling pre-clinical studies. Because the natural product triptolide itself as well as the …See details»
MYELORX LLC Company Profile | Vallejo, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MYELORX LLC of Vallejo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Advisors - myelorx
The Company is advised by a number of highly experienced scientific and business consultants. Michael Andreeff, M.D., Ph.D. Dr. Michael Andreeff received his M.D. and Ph.D. degrees from …See details»
Myelorx LLC - Drug pipelines, Patents, Clinical trials - Synapse
MRx102 is a novel triptolide derivative, acting by converting to triptolide. We investigated whether MRx102 effectively targets primary human AML cells, particularly AML stem/progenitor cells …See details»
MyeloRx - Overview, News & Similar companies | ZoomInfo.com
MyeloRx contact info: Phone number: (510) 530-8263 Website: www.myelorx.com What does MyeloRx do? MyeloRx is a development company advancing a portfolio of triptolide-based …See details»
Myelorx LLC - Company Profile and News - Bloomberg Markets
Myelorx LLC is headquartered in the United States. The company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or...See details»
MyeloRx Company Profile - Office Locations, Competitors ... - Craft
MyeloRx has 1 employees at their 1 location. See insights on MyeloRx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Myelorx - Products, Competitors, Financials, Employees, …
MyeloRx is a biotechnology company focused on developing drugs for oncology and immune-related diseases. Use the CB Insights Platform to explore Myelorx's full profile.See details»
MyeloRx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
MyeloRx is a biotechnology company. Start Free Trial . Chrome ExtensionSee details»
Contact Us - myelorx
Please contact us if you have any questions about the Company or if you would like to learn more about our portfolio of compounds for partnering purposes. Neil R. Ackerman, Ph.D. V.P. of …See details»
MyeloRx - Contacts, Employees, Board Members, Advisors & Alumni
MyeloRx is a biotechnology company. Start Free Trial . Chrome ExtensionSee details»
MyeloRx - Biotech Careers
Triptolide-based drugs Business Areas: Small Molecules. Biotech-Careers is funded in part by the National Science FoundationSee details»
VP, Business Development, Co-founder - MyeloRx - LinkedIn
“Neil is a personable biotechnology executive with vast experience in many therapeutic areas.” at MyeloRx · Experience: MyeloRx · Location: San Carlos · 284 connections on LinkedIn. View …See details»
Partnering - myelorx.com
MyeloRx has an extensive portfolio of proprietary compounds in various stages of pre-clinical development for cancer and immune-based diseases. We are seeking development partners …See details»
MRx 102 - AdisInsight - Springer
MyeloRx is developing MRx 102, a lipophilic prodrug of triptolide, initially for the treatment of acute myeloid leukaemia. MRx 102 has also shown activity in.See details»
Lead Compounds - myelorx
The lead compound, MRx102 is being developed to treat AML under a Phase II SBIR contract from the National Cancer Institute. The compound is a lipophilic prodrug of triptolide, …See details»
MRx 109 - AdisInsight - Springer
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. MyeloRx is developing MRx 109, an immunosuppressant with anti-fibrogenic …See details»
Therapeutic Areas - myelorx.com
Our lead compound, MRx109 is a potent immunosuppressant with anti-fibrogenic properties and has demonstrated activity in a rodent RA model system.See details»